Let's not be pessimistic, let's be realistic. I was viewing the LinkedIn profiles for these guys, their highest rated skills are Mergers/Acquisitions. They've prolonged the extension so many times, not to decline it; why would men like these waste their time? Declan stepping down, CFO coming in, BioSurface being changed to Integumen & they've been consistent in releasing 8Ks via the SEC instantly to keep shareholders informed; for the record, even if they did come out with another extension: I wouldn't care. The opportunity cost here in the long run here, is TREMENDOUS!
